IBD: Poor outcomes after Clostridium difficile infection in IBD

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 6, 2012, Pages 307-308

  Khanna, Sahil ^a   Pardi, Darrell S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; METRONIDAZOLE; SERUM ALBUMIN; VANCOMYCIN;

CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COMORBIDITY; CREATININE BLOOD LEVEL; ENTERITIS; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; SHORT SURVEY;

CLOSTRIDIUM DIFFICILE; COLECTOMY; CREATININE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; PROGNOSIS; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE;

EID: 84861968425     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.87     Document Type: Short Survey

References (10)

1. Khanna, S. & Pardi D. S. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev. Gastroenterol. Hepatol. 4, 409-416 (2010).
2. Khanna, S. et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am. J. Gastroenterol. 107, 89-95 (2011).
3. Ananthakrishnan, A. N., McGinley, E. L. & Binion, D. G. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57, 205-210 (2008).
4. Ananthakrishnan, A. N. et al. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 35, 789-795 (2012).
5. Nguyen, G. C., Kaplan, G. G., Harris, M. L. & Brant, S. R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am. J. Gastroenterol. 103, 1443-1450 (2008).
6. Ananthakrishnan, A. N., McGinley, E. L., Saeian, K. & Binion, D. G. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 17, 976-983 (2011).
7. Issa, M. et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5, 345-351 (2007).
8. Lungulescu, O. A., Cao, W., Gatskevich, E., Tlhabano, L. & Stratidis, J. G. CSI: a severity index for Clostridium difficile infection at the time of admission. J. Hosp. Infect. 79, 151-154 (2011).
9. Ben-Horin, S. et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 7, 981-987 (2009).
10. Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. & Davis, M. B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. 45, 302-307 (2007).